Breaking news CymaBay Therapeutics jumps 25% after Gilead deal news Febbraio 12, 2024 CymaBay Therapeutics Inc.’s shares jumped over 25% on Monday after they announced that Gilead Sciences would acquire the company in a deal worth $4.3 billion. CymaBay Therapeutics Inc. stock surg…
